The Melasma Treatment Market report by Persistence Market Research focuses on the healthcare trends to be pondered about in the upcoming period. When the world at large is gripped with predictive analysis and data science, the healthcare industry cannot remain untouched. These two advancements ascertain that the doctors could monitor, access, or even intervene in real-time reports of the patients.

The Melasma Treatment Market report by Persistence Market Research goes by the changing trend of consumerism all across the healthcare vertical. “Going cashless” is amongst the “new” normals. Inorganic growth has also picked up. Key participants of the healthcare value chain – both – private and public – have joined hands for competing in the ever-demanding landscape.

Melasma is a pigmentary skin disorder. It involves hyperpigmentation which appears as brownish-grey macule or patches on the face and sometimes on the neck.Although the condition is asymptomatic and the main cause for melasma is not cleared. The hormonal change, particularly due to pregnancy and birth control pills, are common triggers of melasma, and often referred to as the “mask of pregnancy”. For instance, according to research studies, melasma is more common in females than males.

Get Sample Copy of this Report@

Rising prevalence of melasma and the vulnerable women population are the major factor propels the melisma treatment market growth during the forecast period. Increasing investment in R&D activities, growing innovations and the emerging new market is primarily driving the melasma treatment market growth. For instance, In August 2016, Cynosure Inc. innovated an aesthetic laser treatment of melasma and body contouring laser treatment at Cynosure APAC Forum.

The rise in the prevalence of skin disorders and easy access to the advanced technology propels the melasma treatment market globally. Additionally, the competitive scenario of the market and strategic collaboration and acquisitions expects to fuel the melasma treatment market. However, low healthcare budget in some developing countries hampers the melasma treatment market growth.

Market Segmentation:

Based on type, the melasma treatment market is segmented as:

  • Medication
  • Hydroquinone
  • Azelaic Acid
  • Kojic Acid
  • Mequinol
  • Arbutin
  • Skin Peels
  • Laser and light treatment
  • Q-Switched Laser Treatment
  • Ablative fractionated laser treatment
  • Non-ablative fractionated laser treatment
  • Strong Pulsed Light Treatment
  • Other Combination techniques
  • Others

Based on the route of administration, the melasma treatment market is segmented as:

  • Oral
  • Topical

Based on the end-user, the melasma treatment market is segmented as:

  • Hospitals
  • Dermatology
  • Others

Request for Table of Content@

The laser and light treatment expects to hold the largest share and witness to dominate the melasma treatment market during the forecast period. The Q-switched laser treatment is the most widely preferred treatment owing to its effectiveness, safety and tolerability as compared to other treatments.

Additionally, the topical route gained more traction in the melasma treatment market owing to its bioavailability and fewer side effects as compared to the oral pills and exposure to ultraviolet rays. Based on application, the dermatology segment gains a large share in the melasma treatment market because of the rising cases of skin disorders.

Key players:

  • Sun Pharmaceuticals Industries Ltd.
  • Abbott Healthcare Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt
  • Cynosure Inc.
  • La Pristine
  • Galderma Laboratories

Access Full Report@

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –